BPC/TB-500

TB-500 / BPC-157 is a research peptide blend combining Thymosin Beta-4 fragment (TB-500) and Body Protection Compound-157 (BPC-157) in equal 10mg/10mg concentration. In controlled laboratory environments, this dual-peptide formulation has been studied for its interaction with cellular migration pathways, angiogenesis-related signaling mechanisms, and cytoskeletal regulatory processes. Due to their complementary molecular characteristics, the combination remains a compound of interest in tissue signaling and regenerative research models. Preclinical investigations have examined TB-500 for its association with actin-binding protein pathways and cellular differentiation research, while BPC-157 has been studied for its interaction with nitric oxide signaling and growth factor expression frameworks. Ongoing scientific evaluations continue to assess their combined influence on intracellular communication, vascular signaling research, and molecular pathway modulation within experimental laboratory settings. This research peptide blend is supplied in a 3ML vial and manufactured under strict laboratory-controlled standards. Each batch undergoes analytical verification to confirm molecular identity, purity, and structural integrity. TB-500 / BPC-157 is intended strictly for laboratory research and analytical purposes only and is not for human consumption.